Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

ClinicalTrials.gov ID: NCT06942949

Public ClinicalTrials.gov record NCT06942949. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 11:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Subjects who still have stone present at Day 30 will be evaluated again at Day 60. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.

Study identification

NCT ID
NCT06942949
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Avvio Medical
Industry
Enrollment
101 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2025
Primary completion
Jul 31, 2026
Completion
Aug 31, 2026
Last update posted
Jun 15, 2026

2025 – 2026

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Arizona State Urological Research Institute Phoenix Arizona 85225 Recruiting
Arkansas Urology Research Center Little Rock Arkansas 72211 Enrolling by invitation
Michael G. Oefelein Clinical Trials Bakersfield California 93301 Active, not recruiting
San Diego Clinical Trials La Mesa California 91942 Recruiting
Golden State Urology Sacramento California 95823 Recruiting
University of Miami Hospital Miami Florida 33136 Recruiting
Georgia Urology Roswell Georgia 300076 Recruiting
Comprehensive Urologic Care Lake Barrington Illinois 60010 Recruiting
Wichita Urology Group Wichita Kansas 67226 Recruiting
Minnesota Urology Woodbury Minnesota 55125 Recruiting
Nebraska Urology Lincoln Nebraska 68516 Enrolling by invitation
Urology Nevada Reno Nevada 89511 Enrolling by invitation
University of Rochester Medical Center Rochester New York 14620 Recruiting
SUNY - Upstate Medical University Syracuse New York 13210 Recruiting
Duke Durham North Carolina 27710 Active, not recruiting
Urology Specialists Clinic Sioux City South Dakota 57108 Enrolling by invitation
Urology San Antonio San Antonio Texas 78229 Recruiting
University of Virginia Charlottesville Virginia 22903 Withdrawn
University of Virginia Community Health Culpeper Virginia 22701 Active, not recruiting
Urology of Virginia Virginia Beach Virginia 23462 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06942949, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06942949 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →